Early-stage lung and prostate cancers, as well as their recurrence, can be detected with a simple blood test, according to a study. Serum-free fatty acids and their metabolites may be used as screening biomarkers to help diagnose early stages of cancer, as well as identify the probability of recovery and recurrence after tumor removal, researchers found.